Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures

NCT07090928 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Arthroscopic Surgery

Interventions

DRUG: 5 ml of 0.5% bupivacaine infiltrated at each port site
DRUG: Placebo

Sponsor

Khyber Teaching Hospital